AMWL · NYSE · Medical - Healthcare Information Services

Amwell (AMWL)

Enterprise software for embedded hybrid healthcare delivery.

$13.58
vs last close+0.37 (+2.80%)
Loading prices…

American Well CorporationAMWL
Health Care

Enterprise software subscriptions and platform visit fees support a hybrid-care model spanning in-person, virtual, and automated care. The technology is designed to be embedded in healthcare clients' existing offerings and workflows.

Enterprise software supports digital care across clinical, retail, school, and home settings. The platform extends beyond telehealth visits to in-person, virtual, and automated care, and can be embedded in healthcare clients' existing offerings and workflows.

Revenue comes from enterprise software subscriptions and fees for visits run on the enterprise and shared-services platforms. The business also includes an accompanying clinical-services platform. The Converge platform brings products, programs, modules, devices, and third-party applications onto a single code base. The model depends on healthcare clients integrating its technology into their care delivery workflows.

Company facts

CEODr. Ido Schoenberg
ListedSep 17, 2020
ExchangeNYSE
HeadquartersBoston, MA
CountryUnited States
Employees562
CIK0001393584
ISINUS03044L2043

Market cap$224.7M
EPS (ttm)−$4.77
P/E (ttm)−2.77
ROE-33.3%
P/B1.02
P/S1.03
Dividend yieldDiv yield
Beta1.02vs XLV 0.70

Price target$12.50−5.4%Average of 15 analysts
ConsensusHold10 of 15 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 13, 2026Truist FinancialTarget
Target: $7.50
Target: $12
Aug 5, 2026Morgan StanleyTarget
Target: $6.50
Target: $13
Aug 5, 2026UBSTarget
Target: $10
Target: $11
Jul 17, 2026Wells FargoReiterate
Rating: Target:
Rating: OverweightTarget: $16
Jun 8, 2026Truist FinancialTarget
Target:
Target: $7.50

Next report
Nov 3, 26
in 41 days
EPS estimate
−$0.66
Revenue estimate
$47.3M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$2.77−$1.73−$1.24−$1.74−$1.43−$0.66−$0.59Pending
Estimate−$3.04−$3.09−$1.84−$1.46−$1.59−$0.77−$0.86−$0.66
Surprise+8.9%+44.0%+32.6%−19.4%+10.1%+14.3%+31.4%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$71.0M$66.8M$70.9M$56.3M$55.3M$54.9M$52.0MPending
Estimate$74.3M$60.2M$61.4M$54.6M$52.6M$51.5M$49.9M$47.3M
Surprise−4.5%+11.1%+15.4%+3.2%+5.1%+6.5%+4.4%
Estimate−$0.66
ReportedDue Nov 3, 2026
Estimate$47.3M
ReportedDue Nov 3, 2026
View details

Debt to equity1.30%
Current ratio290.00%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$61.0M$71.0M$66.8M$70.9M$56.3M$55.3M$54.9M$52.0M
Net income−$43.5M−$42.7M−$18.7M−$19.7M−$32.4M−$24.9M−$10.9M−$9.9M
Net margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income−$47.4M−$42.8M−$30.4M−$20.4M−$29.3M−$25.2M−$12.9M−$9.6M
YoY growthLoss narrowedLoss narrowedLoss narrowedLoss narrowedLoss narrowedLoss narrowedLoss narrowedLoss narrowed

Balance sheet, Jun 30, 2026Cash & short-term investments $195.9M · Total debt $3.0M · Total assets $327.2M · Shareholders' equity $221.2M

Revenue
$52.0M
Operating income
−$9.6M
Net income
−$9.9M
View details

No dividends on record.

Institutions42.32%7.20M shares
59 holders · as of Jun 30, 2026
Insiders12.94%2.20M shares
13 holders · as of Sep 3, 2026
Other44.74%7.61M shares
remainder

17.01M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This company has 3 share classes; every stake here is a share of the whole company.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Senvest Management, LLCInstitution
7.81%1.33M Aas of Jun 30, 2026
Morgan StanleyInstitution
7.52%1.28M Aas of Jun 30, 2026
Cable Car Capital LLCInstitution
5.89%1.00M Aas of Jun 30, 2026
Ido Schoenberg1Insiderdirector, officer: Chairman, co-CEO
4.89%114,920 A · 673,564 Bfiled Feb 13, 2026
Funicular Funds, LPInstitution
4.77%810,551filed Jan 26, 2026
  1. The filed share classes (A, B, COMMON) could not be matched to the company's, so no percentage.

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 1, 2026Paul Francis McNeiceofficer: Chief Accounting Officer−112$11.80
Sep 1, 2026Phyllis Gotlibofficer: President, International−3,573$11.80
Sep 1, 2026Mark Hirschhornofficer: Chief Financial Officer−10,751$11.80
Jul 1, 2026Phyllis Gotlibofficer: President, International−6,677$9.33
Jul 1, 2026Dmitry Zamanskyofficer: Chief Product & Tech. Officer−8,460$9.33
View details

  • Teladoc Health

    Enterprise virtual care and behavioral-health platform overlap

  • Microsoft

    Healthcare video and workflow platform overlap through Teams

  • Amazon

    Virtual care, primary care, pharmacy, and AI-health overlap

  • Oracle

    EHR and health-system workflow overlap through Oracle Health

  • Zoom Communications

    Healthcare video communications overlap with Zoom platforms

  • Doximity

    Clinician-network and telehealth-tool overlap

Compare

CompanyPriceChange
Amwell$13.58+2.80%$224.7M1.0−26.6%
Teladoc Health$6.19−2.60%$1.15B0.5−4.0%
Microsoft$499.61+0.32%$3.70T27.725.511.1+17.8%
Amazon$248.03−2.73%$2.74T20.526.63.5+19.6%
Oracle$146.70−1.62%$429.54B23.417.26.0+29.6%
Zoom Communications$93.03+2.29%$26.67B8.415.15.3+4.9%
Doximity$26.87+1.36%$4.96B31.219.27.6+7.3%
Median23.419.25.7+12.5%